Investment
Features
FeesSafety
Academy
More
Pluang+

RLUSD stablecoin circulation hits 2.49B tokens, market value nears $2.5B on XRP Ledger

Protocol Fundamentals
26 Sep 2026
Tokenpost
View Source
Bullish
RLUSD stablecoin circulation hits 2.49B tokens, market value nears $2.5B on XRP Ledger

The RLUSD stablecoin circulation reached about 2.49 billion tokens on September 27, with its market value approaching $2.5 billion. This growth contributed to the total stablecoin value on the XRP Ledger rising approximately 6% over seven days and 11% over 30 days, reaching around $1.19 billion. RLUSD dominates the XRP Ledger's stablecoin market, accounting for over 92% of its total stablecoin value, roughly $1.1 billion. This highlights RLUSD's strong position and influence within the XRP Ledger ecosystem.

The RLUSD stablecoin circulation and market value provide context for cryptocurrency market activity on Pluang. Of 50 major cryptocurrencies priced on Pluang, 20 rose and 29 fell today. Notable movers include ADA at Rp4.539 with a 1-day change of -3.22%, XLM at Rp3.851 with -2.92%, and XRP at Rp27.346 with -2.86%. This data is as of Sep 27, 2026 09:31 WIB.

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
56 minutes ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
56 minutes ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
56 minutes ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
56 minutes ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
56 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App